Welcome Entering Graduate Student Class of 2025!
The Department of Pharmacology and Cancer Biology is excited to introduce the Class of 2025.
Chidley and Darnell Receive 2025 Faculty Awards
Awards were presented at the School of Medicine Awards Ceremony on May 19th.
Graduation 2025: Congratulations to Pharmacology and Cancer Biology Graduates
Congratulations to seven students in the pharmacology and molecular cancer biology PhD programs who graduated on Sunday, May 11, 2025. They were among 442 students from the Duke University School of Medicine who graduated, marking the successful culmination of their hard work and dedication.
A New Treatment Strategy for Synovial Sarcoma
Synovial sarcoma is a rare, aggressive soft tissue cancer with few effective treatment options, which means patients often have a poor prognosis.
Scientists Hack Cell Entry to Supercharge Cancer Drugs
A study published in the journal Cell from Hui-Kuan Lin and colleagues could help revive drugs once considered too big to work.
How Duke Research Turned Failure into Hope for Patients with Breast Cancer
A breast cancer drug approved in 2023 that was identified in the lab of Donald McDonnell, PhD, is helping women with late-stage breast cancer.
Shutting Down a ‘Dark Kinase’ May Defeat Treatment-Resistant Cancers
A multi-faceted study from Department of Pharmacology and Cancer Biology researchers shows for the first time that blocking an under-studied enzyme called PKN2 may be the key to stopping aggressive, treatment-resistant cancers.
Slotkin Awarded SOT 2025 Distinguished Neurotoxicologist Award
The Distinguished Neurotoxicologist Award recognizes those "who have made important, high-impact scientific, regulatory, or service contributions" to Neurotoxicology.
Abbie Ireland Receives the Dean’s Award for Research Excellence
The student awardees were selected for their publication record, influence on the research direction of their laboratory, and noteworthy and distinctive contributions to the scientific and academic community.
Discovery of Cancer Cell ‘Factories’ Provides Clues to New Treatments
Research led by Greg Wang, PhD, shows how clusters of cancer cells called NUP98 fusions lead to leukemia. The study was published in the journal in Molecular Cell.